Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3546

Actual shortage: 240 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3292 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2017-03-10 2017-06-21 278
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-05-24 2017-06-21 11059
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-07-24 2017-12-20 16680
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2017-07-24 2018-08-15 16683
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2024-09-20 2024-11-01 238230
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2024-12-05 2025-01-31 244883
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-16 2018-10-02 55836
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-03 2019-01-17 71118
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-21 2019-04-05 76582
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-10 2019-05-14 80926
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-30 2019-05-13 82837
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-25 2019-11-04 94734
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-08 2020-07-18 119759
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2020-10-08 124344
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-30 2021-06-07 138340
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-17 2021-10-12 145831

Showing 941 to 960 of 3546

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-SILDENAFIL 100MG TABLET Discontinued 2018-09-08 2018-09-15 60784
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272

Showing 281 to 300 of 366